Crossmark

2g/m2 Ara-c induced more favorable outcome than 1g/m2 Ara-c in CLAG treatment for refractory or relapsed acute myeloid leukemia without increase toxicity: a multicenter propensity score matching analysis

Crossref DOI link: https://doi.org/10.1007/s00277-026-06913-5

Published Online: 2026-03-23

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

liu, Na

Ma, Yan-ru

Pang, Jia-nan

Sun, Meng -wei

sun, Yao

Liu, Ying-jie

Hu, Jiang-wei

li, Yu-hang

Qiao, Zhuo-qing

Duan, Ming-hui

Gao, Su-jun

Jiang, Qian

Hu, Liang-ding
License Information

Text and Data Mining valid from 2026-03-23

Version of Record valid from 2026-03-23
More Information

Article History

Received: 30 November 2025

Accepted: 18 February 2026

First Online: 23 March 2026

Declarations

:

: The study was approved by the Ethics Committee of 5th Medical Center of Chinese PLA General Hospital and the Ethics Approval Number was KY-2023-7-48-1, the study was conducted in accordance with the guidelines of the Declaration of Helsinki., Written informed consent was obtained from all patients in this study.

: The authors declare no competing interests.

Document is current

Any future updates will be listed below